SEOUL — South Korea’s top health agency said Thursday that effective immediately, people under 50 will be offered an alternative to the AstraZeneca COVID-19 vaccine, raised by 20 years from the current cutoff of 30, due to a rare but possible risk of serious blood clots.
The Korea Disease Control and Prevention Agency’s Commissioner Jeong Eun-kyeong told a news briefing that for people in their 50s and above, the benefits of receiving an AstraZeneca vaccine were “clearly greater” than for younger people.
As such, people younger than 50 who had the AstraZeneca vaccine as their first doses will receive Pfizer as their second. There are some 1.6 million first-dose recip…
Keep on reading: S. Korea won’t give AstraZeneca COVID-19 vaccine to people under 50